RBC Capital Markets – February 24
BTIG – February 25
Barclays – March 16
Credit Suisse – March 16
SOUTH JORDAN, Utah, Feb. 10, 2016 -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will present at four investor conferences in the next few weeks.
On Wednesday, February 24, at 10:30 a.m. ET, Merit’s Chairman and Chief Executive Officer Fred P. Lampropoulos will present and participate in one-on-one meetings at the RBC Capital Markets Healthcare Conference at The New York Palace Hotel in New York City.
On Thursday, February 25, Merit’s Chief Financial Officer Bernard Birkett will participate in one-on-one meetings at BTIG’s Snowbird MedTech Conference in Snowbird, Utah.
On Wednesday, March 16, at 9:30 a.m. ET, Lampropoulos will present and participate in one-on-one meetings at Barclays Global Healthcare Conference at Loews Miami Beach Hotel in Miami Beach, Florida.
On Wednesday, March 16, Birkett will participate in one-on-one meetings at the Credit Suisse Under Followed Opportunities (UFO) Conference at the Credit Suisse offices in Boston.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 200 individuals. Merit employs approximately 3,700 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; and Rockland, Massachusetts.
Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Italy Fines Apple €98.6 Million Over App Store Dominance
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



